Department of Child Health, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
Circ Arrhythm Electrophysiol. 2010 Feb;3(1):10-7. doi: 10.1161/CIRCEP.109.882159. Epub 2009 Dec 8.
Data on the clinical presentation and genotype-phenotype correlation of patients with congenital long-QT syndrome (LQTS) diagnosed at perinatal through infantile period are limited. A nationwide survey was conducted to characterize how LQTS detected during those periods is different from that in childhood or adolescence.
Using questionnaires, 58 cases were registered from 33 institutions. Diagnosis (or suspicion) of LQTS was made during fetal life (n=18), the neonatal period (n=31, 18 of them at 0 to 2 days of life), and beyond the neonatal period (n=9). Clinical presentation of LQTS included sinus bradycardia (n=37), ventricular tachycardia/torsades de pointes (n=27), atrioventricular block (n=23), family history of LQTS (n=21), sudden cardiac death/aborted cardiac arrest (n=14), convulsion (n=5), syncope (n=5), and others. Genetic testing was available in 41 (71%) cases, and the genotype was confirmed in 29 (71%) cases, consisting of LQT1 (n=11), LQT2 (n=11), LQT3 (n=6), and LQT8 (n=1). Ventricular tachycardia/torsades de pointes and atrioventricular block were almost exclusively observed in patients with LQT2, LQT3, and LQT8, as well as in those with no known mutation. In LQT1 patients, clues to diagnosis were mostly sinus bradycardia or family history of LQTS. Sudden cardiac death/aborted cardiac arrest (n=14) was noted in 4 cases with no known mutations as well as in 4 genotyped cases, although the remaining 6 did not undergo genotyping. Their subsequent clinical course after aborted cardiac arrest was favorable with administration of beta-blockers and mexiletine and with pacemaker implantation/implantable cardioverter-defibrillator.
Patients with LQTS who showed life-threatening arrhythmias at perinatal periods were mostly those with LQT2, LQT3, or no known mutations. Independent of the genotype, aggressive intervention resulted in effective suppression of arrhythmias, with only 7 deaths recorded.
围生期至婴儿期诊断的先天性长 QT 综合征(LQTS)患者的临床表现和基因型-表型相关性的数据有限。进行了一项全国性调查,以描述这些时期检测到的 LQTS 与儿童或青少年时期的 LQTS 有何不同。
使用问卷,从 33 个机构中登记了 58 例病例。LQTS 的诊断(或怀疑)发生在胎儿期(n=18)、新生儿期(n=31,其中 18 例在出生后 0 至 2 天)和新生儿期后(n=9)。LQTS 的临床表现包括窦性心动过缓(n=37)、室性心动过速/尖端扭转型室性心动过速(n=27)、房室传导阻滞(n=23)、LQTS 家族史(n=21)、心脏性猝死/心搏骤停(n=14)、抽搐(n=5)、晕厥(n=5)和其他。41 例(71%)进行了基因检测,29 例(71%)证实了基因型,包括 LQT1(n=11)、LQT2(n=11)、LQT3(n=6)和 LQT8(n=1)。室性心动过速/尖端扭转型室性心动过速和房室传导阻滞几乎仅见于 LQT2、LQT3 和 LQT8 患者以及无已知突变的患者。在 LQT1 患者中,诊断线索主要是窦性心动过缓或 LQTS 家族史。心脏性猝死/心搏骤停(n=14)发生在 4 例无已知突变的患者和 4 例基因分型的患者中,尽管其余 6 例未进行基因分型。在心脏骤停后,他们的后续临床过程良好,给予β受体阻滞剂和米贝地尔治疗,并植入起搏器/植入式心脏除颤器。
围生期出现危及生命心律失常的 LQTS 患者大多为 LQT2、LQT3 或无已知突变患者。无论基因型如何,积极干预都能有效抑制心律失常,仅记录到 7 例死亡。